The Massachusetts Life Sciences Center is poised to make a series of high-profile announcements at next week’s BIO conference but is keeping mum about most of them.
Susan Windham-Bannister, the center’s president and CEO, said she’ll be announcing the Massachusetts and Israeli teams that are the winners of the first round of new grants for research and development.
The center also will make an announcement involving a “very significant international collaboration” and another involving international companies and Massachusetts academic institutions, Windham-Bannister said, declining to detail either.
But if the Life Sciences Center has been reluctant to reveal its hand about next week’s news, it has been prolific in the number of events it has announced in the run-up to the conference.
Last Thursday, Windham-Bannister joined Gov. Deval Patrick at the ribbon-cutting for Navidea Biopharmaceuticals’ new offices in Andover.
On Monday, Patrick marked the opening of Thermo Fisher Scientific’s new research facility in Tewksbury.
The following day, the Life Sciences Center announced that Xenetic Biosciences, a British drug development company, plans to locate its drug-development offices in the Greater Boston area.
Then, yesterday, the center announced that Batavia Bioservices, headquartered in the Netherlands, has decided to open a U.S. facility in Woburn.
Today, Gov. Patrick is slated to attend the groundbreaking for the new Translational Center for the Cure of Diabetes at the Joslin Diabetes Center in Boston. And tomorrow, Lt. Gov. Tim Murray is scheduled to attend a ribbon-cutting at Forma Therapeutics in Watertown.